Effects of some guanidino compounds on human cerebral arteries

被引:80
作者
Segarra, G
Medina, P
Ballester, RM
Lluch, P
Aldasoro, M
Vila, JM
Lluch, S
机构
[1] Univ Valencia, Fac Med & Odontol, Dept Fisiol, Valencia 46010, Spain
[2] Univ Valencia, Dept Med, Valencia 46010, Spain
关键词
cerebral arteries; endothelium; nitric oxide;
D O I
10.1161/01.STR.30.10.2206
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Accumulation of endogenous guanidino-substituted analogues of L-arginine in chronic renal failure might contribute to some of the vascular and neurological disorders of this pathology. We tested the hypothesis that in human cerebral arteries, some guanidino compounds may increase vascular tone, through nitric oxide (NO) synthase inhibition, and impair endothelium-dependent relaxation. Methods-Rings of human middle cerebral artery were obtained during autopsy of 26 patients who had died 3 to 12 hours before. The rings were suspended in organ baths for isometric recording of tension. We ti;en studied the responses to N-G-monomethyl-L-arginine (L-NMMA), N-G,N-G-dimethyl-L-arginine (asymmetrical dimethylarginine; ADMA), aminoguanidine (AG), and methylguanidine (MG). Results-L-NMMA (10(-6) to 3 x 10(-4) mol/L) and ADMA (10(-6) to 3 x 10(-4) mol/L) caused concentration- and endothelium-dependent contractions (median effective concentrations [EC50] = 1.1 x 10(-5) and 1.6 x 10(-5) mol/L, respectively; E-max = 35.5 +/- 7.9% and 43.9 +/- 5.9% of the response to 100 mmol/L KCl). AG (10(-5) to 3 x 10(-3) mol/L) and MG (10(-5) to 3 x 10(-3) mol/L) produced endothelium-independent contractions (E-max = 44.3 +/- 8.8% and 45.7 +/- 5.8% of the response to 100 mmol/L KCl, respectively). L-Arginine (10(-3) mol/L) prevented the contractions by L-NMMA and ADMA but did not change contractions induced by AC and MG. L-NMMA and ADMA inhibited endothelium-dependent relaxation induced by acetylcholine in a concentration-dependent manner; AG and MG were without effect. Conclusions-The results suggest that the contractions induced by L-NMMA and ADMA are due to inhibition of endothelial NO synthase activity, whereas AG and MG do not affect the synthesis of NO. An increase in the plasma concentration of L-NMMA and ADMA associated with uremia is likely to represent a diminished release or effect of NO, and consequently, an increased cerebrovascular tone in uremic patients is highly conceivable.
引用
收藏
页码:2206 / 2210
页数:5
相关论文
共 49 条
[1]   NG-METHYLARGININE, AN INHIBITOR OF ENDOTHELIUM-DERIVED NITRIC-OXIDE SYNTHESIS, IS A POTENT PRESSOR AGENT IN THE GUINEA-PIG - DOES NITRIC-OXIDE REGULATE BLOOD-PRESSURE INVIVO [J].
AISAKA, K ;
GROSS, SS ;
GRIFFITH, OW ;
LEVI, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 160 (02) :881-886
[2]   Influence of endothelial nitric oxide on adrenergic contractile responses of human cerebral arteries [J].
Aldasoro, M ;
Martinez, C ;
Vila, JM ;
Medina, P ;
Lluch, S .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1996, 16 (04) :623-628
[3]  
ANEMAN A, 1994, CIRC SHOCK, V44, P111
[4]   LOCALIZATION OF NITRIC-OXIDE SYNTHASE INDICATING A NEURAL ROLE FOR NITRIC-OXIDE [J].
BREDT, DS ;
HWANG, PM ;
SNYDER, SH .
NATURE, 1990, 347 (6295) :768-770
[5]   ACETYLCHOLINE RELEASES ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR AND EDRF FROM RAT-BLOOD VESSELS [J].
CHEN, G ;
SUZUKI, H ;
WESTON, AH .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (04) :1165-1174
[6]   AMINOGUANIDINE, A NOVEL INHIBITOR OF NITRIC-OXIDE FORMATION, PREVENTS DIABETIC VASCULAR DYSFUNCTION [J].
CORBETT, JA ;
TILTON, RG ;
CHANG, K ;
HASAN, KS ;
IDO, Y ;
WANG, JL ;
SWEETLAND, MA ;
LANCASTER, JR ;
WILLIAMSON, JR ;
MCDANIEL, ML .
DIABETES, 1992, 41 (04) :552-556
[7]   ENDOTHELIUM-INDEPENDENT CONTRACTIONS OF HUMAN CEREBRAL-ARTERIES IN RESPONSE TO VASOPRESSIN [J].
DEAGUILERA, EM ;
VILA, JM ;
IRURZUN, A ;
MARTINEZ, MC ;
CUESTA, MAM ;
LLUCH, S .
STROKE, 1990, 21 (12) :1689-1693
[8]  
DEAGUILERA EM, 1990, BRIT J PHARMACOL, V99, P439
[9]   GUANIDINO COMPOUND LEVELS IN BRAIN-REGIONS OF NON-DIALYZED UREMIC PATIENTS [J].
DEDEYN, PP ;
MARESCAU, B ;
DHOOGE, R ;
POSSEMIERS, I ;
NAGLER, J ;
MAHLER, C .
NEUROCHEMISTRY INTERNATIONAL, 1995, 27 (03) :227-237
[10]   GUANIDINO COMPOUNDS IN SERUM AND CEREBROSPINAL-FLUID OF NON-DIALYZED PATIENTS WITH RENAL-INSUFFICIENCY [J].
DEDEYN, PP ;
MARESCAU, B ;
CUYKENS, JJ ;
VANGORP, L ;
LOWENTHAL, A ;
DEPOTTER, WP .
CLINICA CHIMICA ACTA, 1987, 167 (01) :81-88